Atopic dermatitis – topical therapy: Do patients apply much too little?

References

• Williams HC. Epidemiology of atopic dermatitis. Clin Exp Dermatol. 2000;25:522–9.
   PubMed Web of Science ®Google Scholar
• Niedner R, Scho¨ pf E. Clinical efficacy of topical glucocorti-coid preparations and other types of dermatics in inflamma-tory diseases, particularly in atopic dermatitis. Curr Probl Dermatol. 1993;21:157–69.
   Google Scholar
• Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ. The management of moderate to severe atopic dermatitis in adults with fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol. 1999;140:1114–21.
   PubMedGoogle Scholar
• Charman CR, Morris AD, Williams HC. Topical cortico-steroid phobia in patients with atopic eczema. Br J Dermatol. 2000;142:931–6.
   PubMed Web of Science ®Google Scholar
• Reitamo S, Wollenberg A, Scho¨ pf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Oinment Study Group. Arch Dermatol. 2000;136:999–1006.
   Google Scholar
• Long CC, Mills CM, Finlay AY. A practical guide to topical therapy in children. Br J Dermatol. 1998;138:293–6.
   PubMed Web of Science ®Google Scholar
• Griffiths WAD, Wilkinson JD. Topical therapy. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling: Textbook of dermatology. 6th ed. Boston: Blackwell Science; 1998. p 3519–64.
   Google Scholar
• Abeck D, Werfel S, Brockow K, Ring J. Die Behandlung des atopischen Ekzems. Hautarzt. 1997;48:379–83.
   PubMedGoogle Scholar
• Kantor I, Milbauer J, Posner M, et al. Efficacy and safety of emollients as adjunctive agents in atopic dermatitis. Today’s Therapeutic Trends. 1993;11:157–67.
   Google Scholar
• Przybilla B, Eberlein-Ko¨ nig B, Rue¨ff F. Practical manage-ment of atopic eczema. Lancet. 1994;343:1342–6.
   PubMedGoogle Scholar
• Przybilla B. Stigmata of the atopic constitution. In: Ruzicka T, Ring J, Przybilla B, editors. Handbook of atopic dermatitis. Berlin, Heidelberg, New York: Springer; 1991. p 31–45.
   Google Scholar
• Billmann-Eberwein C. Modulation von Atopie-Patch-Testreaktionen durch die topische Behandlung der Haut mit einem hautverwandte Lipide enthaltenden Externum. Derm Beruf Umwelt. 2001;49:193–7.
   Google Scholar
• Braun-Falco O, Plewig G, Wolff H. Dermatitis und Ekzemerkrankungen. In: Dermatologie und Venerologie. 4th ed. Berlin: Springer-Verlag; 2002. p 403–77.
   Google Scholar
• Fritsch P. Dermatologie und Venerologie. Lehrbuch und Atlas. Berlin, Heidelberg, New York: Springer; 1998. p 166–82.
   Google Scholar
• British National Formulary, No. 32. London: British Medical Association and the Pharmaceutical Society of Great Britain; 1996.
   Google Scholar
• Long CC, Finlay AY. The fingertip unit-a new practical measure. Clin Exp Dermatol. 1991;16:444–7.
   PubMed Web of Science ®Google Scholar
• Long CC, Finlay AY, Averill RW. The rule of hand: 4 hand areas52 FTU51 g. Arch Dermatol. 1992;128:1129-30[letter].
   Google Scholar
• Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh). 1980;92 (suppl): 44–7.
   Google Scholar
• European Task Force on Atopic Dermatitis, Severity scoring of atopic dermatitis. The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186:23–31.
   Google Scholar
• Oranje AP, Stalder JF, Taie¨b A, Tasset C, de Longueville M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol. 1997;8:28–34.
   PubMedGoogle Scholar
• Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, et al. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol. 1996;106:183–6.
   PubMed Web of Science ®Google Scholar
• Kirby B, Richards HL, Woo P, Hindle E, Main CJ, Griffiths CE. Physical and psychologic measures are neces-sary to assess overall psoriasis severity. J Am Acad Dermatol. 2001;45:72–6.
   PubMed Web of Science ®Google Scholar
• Barth J, Lehr KH, Derendorf H, Mollmann HW, Hohler T, Hochhaus G. Studies on the pharmacokinetics and metabo-lism of prednicarbate after cutaneous and oral administration. Skin Pharmacol. 1993;6:179–86.
   PubMedGoogle Scholar
• Ring J, Brockow K, Abeck D. The therapeutic concept of ‘patient management’ in atopic eczema. Allergy. 1996;51:206–15.
   PubMedGoogle Scholar
• Coskey RJ. Adverse effects of corticosteroids: topical and intralesional. Clin Dermatol. 1986;4:155–60.
   PubMedGoogle Scholar
• Dooms-Goossens AE, Degreef HJ, Marien KJC, Coopman SA. Contact allergy to corticosteroids: A frequently missed diagnosis? J Am Acad Dermatol. 1989;21:538–43.
   Google Scholar
• Richards HL, Fortune DG, O’Sullivan TM, Main CJ, Griffiths CE. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 1999;41:581–3.
   PubMed Web of Science ®Google Scholar
• Draelos ZK. Patient compliance: Enhancing clinician abilities and strategies. J Am Acad Dermatol. 1995;32:S42–8.
   PubMedGoogle Scholar
• Maurice PDL, Saihan EG. Topical steroid requirement in inflammatory skin conditions. Br J Clin Pract. 1985; 39:441–2.
   PubMedGoogle Scholar
• Leung DYM. Atopic dermatitis: New insights and opportu-nities for therapeutic intervention. J Allergy Clin Immunol. 2000;105:860–76.
   PubMed Web of Science ®Google Scholar
• Gieler U, Wahn U, Ring J. Neurodermitisschulung. Dtsch Arztebl. 2001;98A:3202-9.
   Google Scholar